Skip to Main Content

Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae (AV PAS)

Conditions

Diseases of the Cardiovascular System

Phase IV

What is the purpose of this trial?

Brief Summary:

This prospective, global, multicenter, single arm post-approval study is designed to investigate the clinical use and safety of the Lutonix® 035 AV Drug Coated Balloon PTA Catheter in subjects presenting with clinical and hemodynamic abnormalities in native arteriovenous (AV) fistulae located in the upper extremity.

  • Trial with
    C. R. Bard, Inc.
  • Start Date
    02/26/2019
  • End Date
    03/30/2020
Trial Image

For more information about this study, contact:

Patricia Fugal

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/24/2019
  • Study HIC
    #2000023345